Wide-Swensson D, Montal S, Ingemarsson I
Department of Obstetrics and Gynecology, University Hospital, University of Lund, Sweden.
Acta Obstet Gynecol Scand. 1994 Sep;73(8):619-24. doi: 10.3109/00016349409013454.
To study treatment of hypertension in pregnancy in Sweden and compare our results with a similar study published in 1981.
A multiple choice questionnaire was sent to 92 obstetricians throughout Sweden and 88% responded.
Most Swedish obstetricians would treat a woman in the second trimester with blood pressure 140/95 mmHg without antihypertensive medication (83%) in the out-patient clinic (81%). The corresponding figures according to a similar study published in 1981 were 33% and 71% of obstetricians, respectively. Almost all obstetricians (95%) would give antihypertensive treatment if the blood pressure was 170/110 mmHg or more. Betablockers and hydralazine were the most commonly used drugs. Sixteen per cent of obstetricians would use calcium antagonists, drugs not available in the previous study. Treatment with diuretics, methyldopa or diazepam in hypertension was rarely used. Eight per cent of obstetricians would give low-dose aspirin to patients with mild hypertension and 20% to patients with severe hypertension. Fourteen per cent of obstetricians would stop all kind of antihypertensive medication and frequently observe patients with essential hypertension.
Antihypertensive therapy and management of hypertensive disorders of pregnancy show a great disparity among Swedish obstetricians. National strategies might improve the morbidity and mortality associated with hypertensive disorders in pregnancy.
研究瑞典妊娠期高血压的治疗情况,并将我们的结果与1981年发表的一项类似研究进行比较。
向瑞典各地的92位产科医生发送了一份多项选择题问卷,88%的医生做出了回应。
大多数瑞典产科医生会在门诊(81%)对孕中期血压为140/95 mmHg的女性不使用抗高血压药物进行治疗(83%)。根据1981年发表的一项类似研究,相应的产科医生比例分别为33%和71%。如果血压达到170/110 mmHg或更高,几乎所有产科医生(95%)都会给予抗高血压治疗。β受体阻滞剂和肼屈嗪是最常用的药物。16%的产科医生会使用钙拮抗剂,这是之前研究中没有的药物类别。很少使用利尿剂、甲基多巴或地西泮治疗高血压。8%的产科医生会给轻度高血压患者服用小剂量阿司匹林,20%的产科医生会给重度高血压患者服用。14%的产科医生会停用所有抗高血压药物,并密切观察原发性高血压患者。
瑞典产科医生对妊娠期高血压疾病的抗高血压治疗及管理存在很大差异。国家策略可能会改善与妊娠期高血压疾病相关的发病率和死亡率。